标普和纳斯达克内在价值 联系我们

Geron Corporation GERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
55/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.89
+248.5%

共有 50 笔近期内部人交易记录记录,涉及 Geron Corporation (GERN), 包括 35 笔买入9 笔卖出. 内部人买入总额为 $22.27M 内部人卖出总额为 $20.31M.

近期活跃的重要内部人包括 Spiegel Robert J., Andrews Patricia S, Chinoporos Constantine. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — GERN

日期 姓名 职位 交易类型 股数 平均价格 总价值 持股数量
2026-03-31 Spiegel Robert J. Director 限制性股票授予 (RSU) 5,243 $1.49 $7.81K 199,707
2026-03-25 Andrews Patricia S Officer 未知 - - - -
2026-03-25 Andrews Patricia S Director 限制性股票授予 (RSU) 270,000 $1.57 $423.9K 270,000
2026-03-25 Chinoporos Constantine Officer 未知 - - - -
2026-03-25 Chinoporos Constantine Director 限制性股票授予 (RSU) 270,000 $1.57 $423.9K 270,000
2026-02-18 Robertson Michelle EVP, Chief Financial Officer 知情卖出 9,855 $1.94 $19.12K 17,645
2026-02-17 Robertson Michelle EVP, Chief Financial Officer 限制性股票授予 (RSU) 1,660,000 $1.80 $2.99M 1,660,000
2026-02-17 Eid Joseph EVP, R&d; Chief Medical Office 限制性股票授予 (RSU) 2,220,000 $1.80 $4M 2,220,000
2025-12-31 Spiegel Robert J. Director 限制性股票授予 (RSU) 5,918 $1.32 $7.81K 194,464
2025-10-20 Elnawawi Ahmed EVP, Chief Commercial Officer 未知 - - - 10,000
2025-10-20 Elnawawi Ahmed EVP, Chief Commercial Officer 限制性股票授予 (RSU) 3,000,000 $1.27 $3.81M 3,000,000
2025-09-30 Spiegel Robert J. Director 限制性股票授予 (RSU) 5,702 $1.37 $7.81K 188,546
2025-08-07 Semerjian Harout President and CEO 未知 - - - -
2025-08-07 Semerjian Harout President and CEO 限制性股票授予 (RSU) 4,000,000 $1.30 $5.2M 4,000,000
2025-06-30 Spiegel Robert J. Director 限制性股票授予 (RSU) 5,540 $1.41 $7.81K 182,844
2025-05-21 Lawlis V Bryan Director 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-21 Spiegel Robert J. Director 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-21 Aggarwal Gaurav Director 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-21 Molineaux Susan Director 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-21 Bir Dawn Carter Interim President and CEO 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-21 O'farrell Elizabeth G. Director 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-21 Mcdonald John F Director 限制性股票授予 (RSU) 180,000 $1.34 $241.2K 180,000
2025-05-09 Lawlis V Bryan Director 知情买入 13,300 $1.18 $15.67K 13,300
2025-03-31 Spiegel Robert J. Director 限制性股票授予 (RSU) 4,913 $1.59 $7.81K 177,304
2025-02-27 Scarlett John A Chairman, President and CEO 知情买入 12,500 $1.77 $22.06K 12,500
2025-02-27 Samuels Scott Alan EVP, Chief Legal Officer 知情买入 15,000 $1.61 $24.15K 26,682
2025-02-27 Ziegler James EVP, Chief Commercial Officer 知情买入 100,000 $1.60 $160K 100,000
2025-02-18 Grethlein Andrew J EVP, Chief Operating Officer 限制性股票授予 (RSU) 140,000 - - 140,000
2025-02-18 Scarlett John A Chairman, President and CEO 限制性股票授予 (RSU) 410,000 - - 410,000
2025-02-18 Robertson Michelle EVP, Chief Financial Officer 限制性股票授予 (RSU) 110,000 - - 110,000
2025-02-18 Samuels Scott Alan EVP, Chief Legal Officer 限制性股票授予 (RSU) 104,000 - - 104,000
2025-02-18 Ziegler James EVP, Chief Commercial Officer 限制性股票授予 (RSU) 89,000 - - 89,000
2024-12-31 Spiegel Robert J. Director 限制性股票退回 (RSU) 2,206 - - 172,391
2024-12-31 Spiegel Robert J. Director 限制性股票授予 (RSU) 2,206 $3.54 $7.81K 172,391
2024-11-11 Eid Joseph Officer 未知 - - - -
2024-11-11 Eid Joseph EVP, Research and Development 限制性股票退回 (RSU) 2,500,000 $4.12 $10.3M 2,500,000
2024-09-30 Spiegel Robert J. Director 限制性股票退回 (RSU) 1,767 - - 170,185
2024-09-30 Spiegel Robert J. Director 限制性股票授予 (RSU) 1,767 $4.54 $8.02K 170,185
2024-09-09 Ziegler James Officer 未知 - - - -
2024-09-09 Ziegler James EVP, Chief Commercial Officer 限制性股票退回 (RSU) 1,600,000 $4.41 $7.06M 1,600,000
2024-07-08 Grethlein Andrew J EVP, Chief Operating Officer 期权行权(卖出) 452,804 $1.72 $778.82K -
2024-06-28 Spiegel Robert J. Director 限制性股票授予 (RSU) 1,916 $4.24 $8.12K 168,418
2024-06-28 Spiegel Robert J. Director 限制性股票退回 (RSU) 1,916 - - 168,418
2024-06-10 Kapur Anil EVP, Corp Strategy & Cco 知情卖出 421,875 $4.65 $1.96M -
2024-06-10 Feller Faye EVP, Chief Medical Officer 期权行权(卖出) 155,400 $1.30 $201.24K -
2024-06-06 Grethlein Andrew J EVP, Chief Operating Officer 限制性股票授予 (RSU) 452,804 $1.72 $778.82K 452,804
2024-06-06 Scarlett John A Chairman, President and CEO 限制性股票授予 (RSU) 1,000,000 $1.72 $1.72M 1,000,000
2024-06-06 Kapur Anil EVP, Corp Strategy & Cco 限制性股票授予 (RSU) 250,000 $1.43 $357.5K 250,000
2024-06-06 Robertson Michelle EVP, Chief Financial Officer 限制性股票授予 (RSU) 250,000 $2.17 $542.5K 250,000
2024-06-06 Feller Faye EVP, Chief Medical Officer 限制性股票授予 (RSU) 50,000 $1.06 $53K 50,000
知情交易 — 公开市场买卖(最具参考价值) 非知情买入 — 奖励、期权行权、转换 非知情卖出 — 税务代扣、归属出售 中性 — 礼赠、信托、到期
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言